Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Germany
Summary - Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Bexarotene, Atc L01Xf03 For The Period June 1St, 2024 - May 31St, 2026
Deadline - Apr 05, 2026
GT reference number - 80934197
Product classification - Pharmaceutical products
Address - Germany
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 80934197
Document Type - Tender Notices
Description - Description: Section 130a paragraph 8 SGB V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for the medicines to be supplied at the expense of the statutory health insurance companies. With re gard to the relevant legal regulations for the awarding of public contracts, a regular process of active ingredient-related, formal procurement procedures takes place in accordance with the regulations of Part 4 of the GWB by DAK-Gesundheit. For medicinal products to be specified by the bidder in Annex 2 to the contract in relation to the above. Active ingredient, bexarotene, ATC L01XF03, DAK-Gesundheit intends to conclude drug discount agreement
Gt Ref Id - 80934197
Deadline - Apr 05, 2026
Similar Tenders :
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database